← All trials
NCT01536106
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2013
- Primary completion
- Jan 31, 2015
- Completion date
- Mar 31, 2015
- First posted
- Feb 20, 2012
- Last posted
- Sep 4, 2013
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- TotipotentRXLead sponsor
- Care Hospital, HyderabadOverall official - principal investigator
- Fortis Escorts Heart Institute and Research CentreOverall official - principal investigator
- TotipotentRXStudy chair
- TotipotentRXStudy director
- TotipotentRXOfficial
- Care Hospital, HyderabadOfficial
- Fortis Escorts Heart Institute and Research CentreOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.